ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995

Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;

January 10, 2003

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993

Tempero, Johnson To Lead ASCO

March 28, 2003

Chemo, Radiation Improves DFS In Head & Neck Cancer

May 28, 2004